Report Detail

Other Global EGFR Mutation Test Market Professional Survey Report 2019

  • RnM3744020
  • |
  • 13 September, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Other

Global EGFR Mutation Test Market Professional Survey Report 2019

Table of Contents

    Executive Summary

      1 Industry Overview of EGFR Mutation Test

      • 1.1 Definition of EGFR Mutation Test
      • 1.2 EGFR Mutation Test Segment by Type
        • 1.2.1 Global EGFR Mutation Test Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 DNA Sequencing
        • 1.2.3 Kits
      • 1.3 EGFR Mutation Test Segment by Applications
        • 1.3.1 Global EGFR Mutation Test Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Cancer Hospitals
        • 1.3.3 Clinical Research Institutes
      • 1.4 Global EGFR Mutation Test Overall Market
        • 1.4.1 Global EGFR Mutation Test Revenue (2014-2025)
        • 1.4.2 Global EGFR Mutation Test Production (2014-2025)
        • 1.4.3 North America EGFR Mutation Test Status and Prospect (2014-2025)
        • 1.4.4 Europe EGFR Mutation Test Status and Prospect (2014-2025)
        • 1.4.5 China EGFR Mutation Test Status and Prospect (2014-2025)
        • 1.4.6 Japan EGFR Mutation Test Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia EGFR Mutation Test Status and Prospect (2014-2025)
        • 1.4.8 India EGFR Mutation Test Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of EGFR Mutation Test
      • 2.3 Manufacturing Process Analysis of EGFR Mutation Test
      • 2.4 Industry Chain Structure of EGFR Mutation Test

      3 Development and Manufacturing Plants Analysis of EGFR Mutation Test

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global EGFR Mutation Test Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of EGFR Mutation Test
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 EGFR Mutation Test Production and Capacity Analysis
      • 4.2 EGFR Mutation Test Revenue Analysis
      • 4.3 EGFR Mutation Test Price Analysis
      • 4.4 Market Concentration Degree

      5 EGFR Mutation Test Regional Market Analysis

      • 5.1 EGFR Mutation Test Production by Regions
        • 5.1.1 Global EGFR Mutation Test Production by Regions
        • 5.1.2 Global EGFR Mutation Test Revenue by Regions
      • 5.2 EGFR Mutation Test Consumption by Regions
      • 5.3 North America EGFR Mutation Test Market Analysis
        • 5.3.1 North America EGFR Mutation Test Production
        • 5.3.2 North America EGFR Mutation Test Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America EGFR Mutation Test Import and Export
      • 5.4 Europe EGFR Mutation Test Market Analysis
        • 5.4.1 Europe EGFR Mutation Test Production
        • 5.4.2 Europe EGFR Mutation Test Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe EGFR Mutation Test Import and Export
      • 5.5 China EGFR Mutation Test Market Analysis
        • 5.5.1 China EGFR Mutation Test Production
        • 5.5.2 China EGFR Mutation Test Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China EGFR Mutation Test Import and Export
      • 5.6 Japan EGFR Mutation Test Market Analysis
        • 5.6.1 Japan EGFR Mutation Test Production
        • 5.6.2 Japan EGFR Mutation Test Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan EGFR Mutation Test Import and Export
      • 5.7 Southeast Asia EGFR Mutation Test Market Analysis
        • 5.7.1 Southeast Asia EGFR Mutation Test Production
        • 5.7.2 Southeast Asia EGFR Mutation Test Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia EGFR Mutation Test Import and Export
      • 5.8 India EGFR Mutation Test Market Analysis
        • 5.8.1 India EGFR Mutation Test Production
        • 5.8.2 India EGFR Mutation Test Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India EGFR Mutation Test Import and Export

      6 EGFR Mutation Test Segment Market Analysis (by Type)

      • 6.1 Global EGFR Mutation Test Production by Type
      • 6.2 Global EGFR Mutation Test Revenue by Type
      • 6.3 EGFR Mutation Test Price by Type

      7 EGFR Mutation Test Segment Market Analysis (by Application)

      • 7.1 Global EGFR Mutation Test Consumption by Application
      • 7.2 Global EGFR Mutation Test Consumption Market Share by Application (2014-2019)

      8 EGFR Mutation Test Major Manufacturers Analysis

      • 8.1 Abbott
        • 8.1.1 Abbott EGFR Mutation Test Production Sites and Area Served
        • 8.1.2 Abbott Product Introduction, Application and Specification
        • 8.1.3 Abbott EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Merck
        • 8.2.1 Merck EGFR Mutation Test Production Sites and Area Served
        • 8.2.2 Merck Product Introduction, Application and Specification
        • 8.2.3 Merck EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Thermo Fisher Scientific
        • 8.3.1 Thermo Fisher Scientific EGFR Mutation Test Production Sites and Area Served
        • 8.3.2 Thermo Fisher Scientific Product Introduction, Application and Specification
        • 8.3.3 Thermo Fisher Scientific EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Illumina
        • 8.4.1 Illumina EGFR Mutation Test Production Sites and Area Served
        • 8.4.2 Illumina Product Introduction, Application and Specification
        • 8.4.3 Illumina EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 BioMerieux
        • 8.5.1 BioMerieux EGFR Mutation Test Production Sites and Area Served
        • 8.5.2 BioMerieux Product Introduction, Application and Specification
        • 8.5.3 BioMerieux EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 QIAGEN
        • 8.6.1 QIAGEN EGFR Mutation Test Production Sites and Area Served
        • 8.6.2 QIAGEN Product Introduction, Application and Specification
        • 8.6.3 QIAGEN EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Agilent Technologies
        • 8.7.1 Agilent Technologies EGFR Mutation Test Production Sites and Area Served
        • 8.7.2 Agilent Technologies Product Introduction, Application and Specification
        • 8.7.3 Agilent Technologies EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Hologic
        • 8.8.1 Hologic EGFR Mutation Test Production Sites and Area Served
        • 8.8.2 Hologic Product Introduction, Application and Specification
        • 8.8.3 Hologic EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Novartis
        • 8.9.1 Novartis EGFR Mutation Test Production Sites and Area Served
        • 8.9.2 Novartis Product Introduction, Application and Specification
        • 8.9.3 Novartis EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Roche
        • 8.10.1 Roche EGFR Mutation Test Production Sites and Area Served
        • 8.10.2 Roche Product Introduction, Application and Specification
        • 8.10.3 Roche EGFR Mutation Test Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Genomic Health

      9 Development Trend of Analysis of EGFR Mutation Test Market

      • 9.1 Global EGFR Mutation Test Market Trend Analysis
        • 9.1.1 Global EGFR Mutation Test Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 EGFR Mutation Test Regional Market Trend
        • 9.2.1 North America EGFR Mutation Test Forecast 2019-2025
        • 9.2.2 Europe EGFR Mutation Test Forecast 2019-2025
        • 9.2.3 China EGFR Mutation Test Forecast 2019-2025
        • 9.2.4 Japan EGFR Mutation Test Forecast 2019-2025
        • 9.2.5 Southeast Asia EGFR Mutation Test Forecast 2019-2025
        • 9.2.6 India EGFR Mutation Test Forecast 2019-2025
      • 9.3 EGFR Mutation Test Market Trend (Product Type)
      • 9.4 EGFR Mutation Test Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 EGFR Mutation Test Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.   
        Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.

        The global EGFR Mutation Test market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on EGFR Mutation Test volume and value at global level, regional level and company level. From a global perspective, this report represents overall EGFR Mutation Test market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of EGFR Mutation Test in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their EGFR Mutation Test manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Abbott
        Merck
        Thermo Fisher Scientific
        Illumina
        BioMerieux
        QIAGEN
        Agilent Technologies
        Hologic
        Novartis
        Roche
        Genomic Health

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        DNA Sequencing
        Kits

        Segment by Application
        Cancer Hospitals
        Clinical Research Institutes


        Summary:
        Get latest Market Research Reports on EGFR Mutation Test. Industry analysis & Market Report on EGFR Mutation Test is a syndicated market report, published as Global EGFR Mutation Test Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of EGFR Mutation Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,801.12
        4,201.67
        5,602.23
        3,172.24
        4,758.36
        6,344.48
        377,594.00
        566,391.00
        755,188.00
        248,805.90
        373,208.85
        497,611.80
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report